Hypoxia-inducible factor prolyl hydroxylase inhibitor, C-terminal fibroblast growth factor 23 fragments, and hepcidin
- 1 September 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 100 (3), 709
- https://doi.org/10.1016/j.kint.2021.04.038
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferroneKidney International, 2021
- C-FGF23 peptide alleviates hypoferremia during acute inflammationHaematologica, 2020
- Effects of erythropoietin on fibroblast growth factor 23 in mice and humansNephrology Dialysis Transplantation, 2018
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formationProceedings of the National Academy of Sciences of the United States of America, 2009